Outcome of Patients with Myelofibrosis Relapsing after Allogeneic Stem Cell Transplant: A Retrospective Study by the Chronic Malignancies Working Party of EBMT

被引：0

作者：

McLornan, D. ^{[1
]}

Syzdlo, R. ^{[2
]}

van Biezen, A. ^{[3
]}

Koster, L. ^{[3
]}

Bacigalupo, A. ^{[4
]}

Schleuning, M. ^{[5
]}

Finke, J. ^{[6
]}

Vitek, A. ^{[7
]}

Peniket, A. ^{[8
]}

Beelen, D. ^{[9
]}

Craddock, C. ^{[10
]}

Apperley, J. ^{[2
]}

Bethge, W. ^{[11
]}

Blaise, D. ^{[12
]}

Niederwieser, D. ^{[13
]}

Volin, L. ^{[14
]}

Dreger, P. ^{[15
]}

Michallet, M. ^{[16
]}

Nagler, A. ^{[17
]}

Arnold, R. ^{[18
]}

Klyuchnikov, E. ^{[19
]}

Olavarria, E. ^{[2
]}

Kroeger, N. ^{[19
]}

机构：

[1] Kings Coll Hosp London, Haematol Med, London, England

[2] Hammersmith Hosp, Haematol, London, England

[3] Univ Med Ctr, EBMT Data Off, Leiden, Netherlands

[4] Osped San Martino Genova, Haematol, Genoa, Italy

[5] Wisebaden Univ, Deutsch Klin Diagnost, Wisebaden, Germany

[6] Univ Freiburg, Haematol, Hugstetter Str 55, D-79106 Freiburg, Germany

[7] Inst Hematol & Blood Transfus, Prague, Czech Republic

[8] Churchill Hosp, Haematol, Oxford OX3 7LJ, England

[9] Univ Hosp, Haematol, Essen, Germany

[10] Queen Elizabeth Hosp, Haematol, Birmingham B15 2TH, W Midlands, England

[11] Univ Tubingen, Haematol, Tubingen, Germany

[12] Inst J Paoli I Calmettes, F-13009 Marseille, France

[13] Univ Hosp Leipzig, Leipzig, Germany

[14] HUCH Comprehens Canc Ctr, Helsinki, Finland

[15] Heidelberg Univ, Heidelberg, Germany

[16] Ctr Hosp Lyon Sud, Lyon, France

[17] Chaim Sheba Med Ctr, Tel Aviv, Israel

[18] Charite, D-13353 Berlin, Germany

[19] Univ Hosp Eppendorf, Hamburg, Germany

来源：

BONE MARROW TRANSPLANTATION | 2016年 / 51卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O128

引用

页码：S74 / S75

页数：2

共 50 条

[21] Outcomes of mismatched related allogeneic stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT
van Gorkom, G.
van Gelder, M.
Ziagkos, D.
Koster, L.
Koc, Y.
van Lint, M.
Ciceri, F.
Selleslag, D.
Blaise, D.
Foa, R.
Beelen, D.
Corradini, P.
Moreno, C.
Carlson, K.
Solano, C.
Mueller, L. P.
Castagna, L.
Tischer, J.
Hilgendorf, I.
Hallek, M.
Bittenbring, J.
Theobald, M.
Schetelig, J.
Kroeger, N.
BONE MARROW TRANSPLANTATION, 2016, 51 : S293 - S294
[22] Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT
Avichai Shimoni
Myriam Labopin
Jürgen Finke
Fabio Ciceri
Eric Deconinck
Nicolaus Kröger
Martin Gramatzki
Matthias Stelljes
Didier Blaise
Friedrich Stoelzel
Patrice Chevallier
Ernst Holler
Nathalie Fegueux
Mohamad Mohty
Arnon Nagler
Blood Cancer Journal, 9
[23] Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT
Shimoni, Avichai
Labopin, Myriam
Finke, Jurgen
Ciceri, Fabio
Deconinck, Eric
Kroger, Nicolaus
Gramatzki, Martin
Stelljes, Matthias
Blaise, Didier
Stoelzel, Friedrich
Chevallier, Patrice
Holler, Ernst
Fegueux, Nathalie
Mohty, Mohamad
Nagler, Arnon
BLOOD CANCER JOURNAL, 2019, 9 (12)
[24] Outcomes Following Second Allogenic Haematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of EBMT
Nabergoj, Mitja
Wang, Junfeng
Robin, Marie
Kroger, Nicolaus
Angelucci, Emanuele
Poire, Xavier
Passweg, Jakob R.
Dreger, Peter
Platzbecker, Uwe
Robinson, Stephen
Rambaldi, Alessandro
Sengeloev, Henrik
Bornhauser, Martin
Stelljes, Matthias
Ciceri, Fabio
Mayer, Jiri
Ladetto, Marco
de Wreede, Liesbeth C.
Koster, Linda
Hayden, Patrick John
Czerw, Tomasz
Boluda, Juan Carlos Hernandez
McLornan, Donal P.
Chalandon, Yves
Yakoub-Agha, Ibrahim
BLOOD, 2019, 134
[25] Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT
Heidenreich, Silke
Ziagkos, Dimitris
de Wreede, Liesbeth C.
van Biezen, Anja
Finke, Juergen
Platzbecker, Uwe
Niederwieser, Dietger
Einsele, Hermann
Bethge, Wolfgang
Schleuning, Michael
Beelen, Dietrich W.
Tischer, Johanna
Nagler, Arnon
Glass, Bertram
Maertens, Johan
Yanez, Lucrecia
Beguin, Yves
Sill, Heinz
Scheid, Christof
Stelljes, Matthias
Ganser, Arnold
Zachee, Pierre
Selleslag, Dominik
de Witte, Theo
Robin, Marie
Kroeger, Nicolaus
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (01) : 44 - 52
[26] Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Robin, Marie
Iacobelli, Simona
Koster, Linda
Passweg, Jakob
Avenoso, Daniele
Wilson, Keith M. O.
Salmenniemi, Urpu
Dreger, Peter
von dem Borne, Peter
Snowden, John A.
Robinson, Stephen
Finazzi, Maria Chiara
Schroeder, Thomas
Collin, Matthew
Eder, Matthias
Forcade, Edouard
Loschi, Michael
Bramanti, Stefania
Antonio Perez-Simon, Jose
Czerw, Tomasz
Polverelli, Nicola
Drozd-Sokolowska, Joanna
Raj, Kavita
Carlos Hernandez-Boluda, Juan
McLornan, Donal P.
BONE MARROW TRANSPLANTATION, 2024, 59 (07) : 928 - 935
[27] Treosulfan Compared to Busulfan in Allogeneic Haematopoietic Stem Cell Transplantation for Myelofibrosis: A Registry-Based Study from the Chronic Malignancies Working Party of the EBMT
Robin, Marie
Iacobelli, Simona
Passweg, Jakob R.
Koster, Linda
Potter, Victoria
Wilson, Keith
Salmenniemi, Urpu
Dreger
Peter, von dem Borne, Sr.
Snowden, John
Stephen, Robinson, Jr.
Finazzi, Maria Chiara
Schroeder, Thomas
Matthew, Collin P., Sr.
Eder, Matthias
Forcade, Edouard
Loschi, Michael
Bramanti, Stefania
Perez-Simon, Jose A.
Czerw, Tomasz
Polverelli, Nicola
Drozd-Sokolowska, Joanna
Raj, Kavita
Hernandez Boluda, Juan Carlos
McLornan, Donal P.
BLOOD, 2023, 142
[28] Prognostic Value of Cpss Cytogenetic Risk Classification in Patients with CMML after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Multicenter Study of the Chronic Malignancies Working Party of the EBMT
Koenecke, Christian
Eikema, Dirk-Jan
Hazelaar, Sheree
Beelen, Dietrich W.
Potter, Victoria
Bornhaeuser, Martin
Kroeger, Nicolaus
Finke, Juergen
Niederwieser, Dietger
Dreger, Peter
Chalandon, Yves
Ganser, Arnold
Maertens, Johan
Milpied, Noel
Kobbe, Guido
Itala-Remes, Maija
Sengeloev, Henrik
Socie, Gerard
Ljungman, Per
Blaise, Didier
Meijer, Ellen
Veelken, Hendrik
Onida, Francesco
Robin, Marie
Yakoub-Agha, Ibrahim
BLOOD, 2018, 132
[29] Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party
Brijs, J.
Peczynski, C.
Boreland, W.
Cuoghi, A.
Maertens, J.
Mohty, M.
Kroeger, N.
Nakov, P.
Broers, A. E. C.
Eder, M.
Arroyo, C. Herrera
Kaufmann, M.
Ram, R.
Schaap, N. P. M.
Graham, C.
Mussetti, A.
Penack, O.
Moiseev, I.
Peric, Z.
Schoemans, H.
BONE MARROW TRANSPLANTATION, 2024, : 415 - 417
[30] Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable - a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Drozd-Sokolowska, Joanna
Gras, Luuk
Zinger, Nienke
Zahrani, Mohsen Al
Passweg, Jakob
Byrne, Jenny
Ho, Aloysius
Huang, Xiao-jun
Kroeger, Nicolaus
Mayer, Jiri
Russo, Domenico
De Becker, Ann
Tbakhi, Abdelghani
Stamatoullas, Aspasia
Valerius, Thomas
Hayden, Patrick
McLornan, Donal P.
Onida, Francesco
Scheid, Christof
Robin, Marie
Yakoub-Agha, Ibrahim
BONE MARROW TRANSPLANTATION, 2023, 58 (02) : 222 - 225

← 1 2 3 4 5 →